Goldman Sachs’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Buy |
|
|||||
|
2025
Q1 | $1.26M | Sell |
|
|||||
|
2024
Q4 | $2.13M | Buy |
|
|||||
|
2024
Q3 | $1.85M | Sell |
|
|||||
|
2024
Q2 | $1.38M | Sell |
|
|||||
|
2024
Q1 | $4.53M | Buy |
|
|||||
|
2023
Q4 | $236K | Buy |
|
|||||
|
2023
Q3 | $246K | Sell |
|
|||||
|
2023
Q2 | $58.4K | Sell |
|
|||||
|
2023
Q1 | $39.4K | Sell |
|
|||||
|
2022
Q4 | $40.7K | Buy |
|
|||||
|
2022
Q3 | $85K | Buy |
|
|||||
|
2022
Q2 | $110K | Sell |
|
|||||
|
2022
Q1 | $244K | Buy |
|
|||||
|
2021
Q4 | $353K | Buy |
|